StonvexLoading…
StonvexStonvexStonvexCore line items from CSW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $878.30M | $792.84M | $757.90M | $626.43M |
Operating Income | $181.25M | $159.12M | $139.07M | $97.38M |
Net Income | $136.65M | $101.65M | $96.44M | $66.39M |
EPS (Diluted) | $8.38 | $6.52 | $6.20 | $4.20 |
Total Assets | $1.38B | $1.04B | $1.04B | $995.36M |
Total Liabilities | $286.63M | $408.25M | $499.31M | $510.95M |
Cash & Equivalents | $225.84M | $22.16M | $18.45M | $16.62M |
Free Cash Flow OCF − CapEx | $152.10M | $147.76M | $107.50M | $53.44M |
Shares Outstanding | 16.31M | 15.58M | 15.55M | 15.81M |